Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on July 2, 2026 by admin

Neuromodulation of Mood Switch Circuitry in Bipolar Disorder

Conditions: Bipolar Disorder (BD); Bipolar 1 Depression; rTMS; fMRI

Interventions: Device: MagVenture MagPro TMS system; Device: Sham Stimulation

Sponsors: Weill Medical College of Cornell University; BD2 LLC

Not yet recruiting
CategoriesClinicalTrials.gov TagsBipolar, Depression, Medical device, Mood and emotional regulation, News Approved

Post navigation

Previous PostPrevious Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
Next PostNext Accelerated iTBS for PTSD and Depression
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.